In hormone-independent prostate cancer, CXCL5 (also known as ENA78) enhances EGR1 transcription via the RAF–MEK–ERK pathway, thus increasing SNAIL expression, tumor cell metastasis, and EMT (28). The gene discussed is EGR1; the disease is neoplasm.